Cullen/Frost Bankers, Inc. (CFR) Balance Sheet
As of 2026-06-30 (10-Q), Cullen/Frost Bankers, Inc. (CFR) reported total assets of $53.9B, total liabilities of $49.3B and shareholders' equity of $4.6B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $6.5B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CFRCullen/Frost Bankers, Inc.Follow CFR — free
—
Price chart with a free account
- Market cap
- 9.8B
- P/E TTM
- 14.8
- Dividend yield
- 2.6%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.82 | 2.91 | 3.52 | 4.56 | — | — | — | — | — | 3.79 | 10.29 | 16.58 | 12.03 | 8.69 | 10.23 | 8.87 | 6.47 | |
| Total assets | 17.62 | 20.32 | 23.12 | 24.31 | 28.28 | 28.57 | 30.20 | 31.75 | 32.29 | 34.03 | 42.39 | 50.88 | 52.89 | 50.85 | 52.52 | 53.04 | 53.88 | |
| Total liabilities | 15.56 | 18.03 | 20.71 | 21.80 | 25.43 | 25.68 | 27.19 | 28.45 | 28.92 | 30.12 | 38.10 | 46.44 | 49.76 | 47.13 | 48.62 | 48.47 | 49.26 | |
| Shareholders' equity | 2.06 | 2.28 | 2.42 | 2.51 | 2.85 | 2.89 | 3.00 | 3.30 | 3.37 | 3.91 | 4.29 | 4.44 | 3.14 | 3.72 | 3.90 | 4.57 | 4.62 |
USD billions · SEC XBRL
Cullen/Frost Bankers, Inc. — questions
- How much cash does Cullen/Frost Bankers, Inc. have?
- $6.5B in cash and cash equivalents as of 2026-06-30.
- What are Cullen/Frost Bankers, Inc.'s total assets?
- $53.9B as of 2026-06-30.
- What is Cullen/Frost Bankers, Inc.'s shareholders' equity?
- $4.6B as of 2026-06-30.
Every figure on this page comes from Cullen/Frost Bankers, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.